Literature DB >> 26690012

Survey assessing obesity policies for assisted reproductive technology in the United States.

Leah Kaye1, Carolina Sueldo1, Lawrence Engmann1, John Nulsen1, Claudio Benadiva2.   

Abstract

OBJECTIVE: To determine what assisted reproductive technologies (ART) policies, if any, have been instituted in response to an increasingly overweight and obese patient population.
DESIGN: Cross-sectional survey.
SETTING: University-affiliated IVF clinic. PATIENT(S): Women in the overweight and obese body mass index (BMI) categories seeking ART treatments. INTERVENTION(S): Anonymous survey sent to medical directors at 395 IVF centers listed in Society for Assisted Reproductive Technology database. MAIN OUTCOME MEASURE(S): Assessment of recommendations, policies, and restrictions for patients who are overweight/obese and who desire treatment for infertility, including in IVF, IUI, and donor egg cycles. RESULT(S): Seventy-seven anonymous responses were received (19.5% response rate): 64.9% of centers have a formal policy for obesity, and 84% of those have a maximum BMI at which they will perform IVF, while 38% of those have a maximum BMI for performing IUI; 64.6% of respondents reported anesthesia requirements/concerns as the primary criteria for patient exclusion. Other primary considerations included safety during ongoing pregnancy and ART outcomes. CONCLUSION(S): Centers that have policies regarding obesity and access to ART consider efficacy, procedural safety, safety in pregnancy, and overall health status. Policies vary widely. The patient's autonomy must be balanced with nonmaleficence and the avoidance of interventions that may be unsafe both immediately and long term.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI; Obesity; assisted reproductive technology; policy

Mesh:

Year:  2015        PMID: 26690012     DOI: 10.1016/j.fertnstert.2015.11.035

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Body mass index restrictions in fertility treatment: a national survey of OB/GYN subspecialists.

Authors:  Angela S Kelley; Sylvia E Badon; Michael S M Lanham; Senait Fisseha; Molly B Moravek
Journal:  J Assist Reprod Genet       Date:  2019-04-08       Impact factor: 3.412

2.  The association of obesity with euploidy rates in women undergoing in vitro fertilization with preimplantation genetic testing.

Authors:  Stephanie Hallisey; Reeva Makhijani; Jeffrey Thorne; Prachi Godiwala; John Nulsen; Claudio Benadiva; Daniel Grow; Lawrence Engmann
Journal:  J Assist Reprod Genet       Date:  2022-10-10       Impact factor: 3.357

3.  Outcome of assisted reproductive technology in overweight and obese women.

Authors:  Antonio MacKenna; Juan Enrique Schwarze; Javier A Crosby; Fernando Zegers-Hochschild
Journal:  JBRA Assist Reprod       Date:  2017-06-01

Review 4.  Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.

Authors:  Hellas Cena; Luca Chiovato; Rossella E Nappi
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

Review 5.  Recent advances in understanding the relationship between long- and short-term weight change and fertility.

Authors:  Audrey J Gaskins
Journal:  F1000Res       Date:  2018-10-26

6.  Irresponsibly Infertile? Obesity, Efficiency, and Exclusion from Treatment.

Authors:  Rebecca C H Brown
Journal:  Health Care Anal       Date:  2019-06

7.  Impact of class III obesity on outcomes and complications of transvaginal ultrasound-guided oocyte pickup.

Authors:  Tina Liang; Kelsey Ruetz; Olga Haakman; Angelos Vilos; George Vilos; Basim Abu-Rafea
Journal:  F S Rep       Date:  2020-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.